{"DataElement":{"publicId":"6771252","version":"1","preferredName":"Breast DCIS Histologic Subtype Classification Type","preferredDefinition":"The histologic subtype of a breast carcinoma entirely confined to the mammary ducts.","longName":"DCIS_HIST_SUBTP","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"6771239","version":"1","preferredName":"Breast DCIS Histologic Subtype Classification","preferredDefinition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS._Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._A group forming a type within a larger type._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"2413053v1.0:2429763v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"2413053","version":"1","preferredName":"DCIS","preferredDefinition":"Ductal carcinoma in situ (DCIS) is a carcinoma entirely confined to the mammary ducts.  There is no evidence of invasion of the basement membrane.  Currently, DCIS is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS. --2002","longName":"C2924","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"01D4D496-BCED-3A9F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-30","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-09-30","modifiedBy":"ONEDATA","dateModified":"2005-09-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2429763","version":"1","preferredName":"Histologic Subtype Classification","preferredDefinition":"Of or relating to histology.:Subtype; a group forming a type within a larger type.:Classification; the grouping of things into classes or categories.","longName":"C25526:C25696:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"049B5946-2F66-2FE1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-11-16","modifiedBy":"ONEDATA","dateModified":"2005-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A1B1051-8461-78B4-E053-F662850A25B7","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeDescription":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-30-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6771241","version":"1","preferredName":"Breast DCIS Subtype Type","preferredDefinition":"A carcinoma entirely confined to the mammary ducts.  It is also known as DCIS.  There is no evidence of invasion of the basement membrane.  Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS._Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._Something distinguishable as an identifiable class based on common qualities._A group forming a type within a larger type._Something distinguishable as an identifiable class based on common qualities.","longName":"6771241v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Data not available","valueDescription":"Source Data Not Available","ValueMeaning":{"publicId":"4842575","version":"1","preferredName":"Source Data Not Available","longName":"4842575","preferredDefinition":"Data from an original source is not present, accessible or ready for use or service.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Source Data Not Available","conceptCode":"C67329","definition":"Data from an original source is not present, accessible or ready for use or service.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"173BF844-9709-E098-E050-BB89AD431F3E","latestVersionIndicator":"Yes","beginDate":"2015-05-29","endDate":null,"createdBy":"LEEW","dateCreated":"2015-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4E9085-B6C8-31BC-E053-F662850A02ED","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682944","version":"1","preferredName":"Unknown","longName":"5682944","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9AE5-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"GDEEN","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4E9085-B6D2-31BC-E053-F662850A02ED","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Non-invasive papillary carcinoma","valueDescription":"Intraductal Papillary Breast Carcinoma","ValueMeaning":{"publicId":"3669445","version":"1","preferredName":"Intraductal Papillary Breast Carcinoma","longName":"3669445","preferredDefinition":"A non-invasive breast adenocarcinoma located in a distended duct. It is characterized by the presence of papillary structures with fibrovascular stalks. In the absence of ductal carcinoma in situ or invasive carcinoma in adjacent tissues, the prognosis is usually favorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Papillary Ductal Carcinoma In Situ","conceptCode":"C4190","definition":"Breast ductal carcinoma in situ characterized by the presence of filiform arborizing fibrovascular cores lined by neoplastic ductal epithelium. (WHO 2019)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-75CF-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A1B1051-8498-78B4-E053-F662850A25B7","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"ONEDATA","dateModified":"2019-05-30","deletedIndicator":"No"},{"value":"Micropapillary","valueDescription":"Intraductal Micropapillary Breast Carcinoma","ValueMeaning":{"publicId":"3249012","version":"1","preferredName":"Intraductal Micropapillary Breast Carcinoma","longName":"3249012","preferredDefinition":"An intraductal papillary carcinoma in which the neoplastic epithelial cells are arranged in micropapillary patterns.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Micropapillary Ductal Carcinoma In Situ","conceptCode":"C5139","definition":"Breast ductal carcinoma in situ characterized by the presence of neoplastic epithelial cells arranged in micropapillary patterns.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-157C-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A1B1051-84AC-78B4-E053-F662850A25B7","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"ONEDATA","dateModified":"2019-05-30","deletedIndicator":"No"},{"value":"Cribriform","valueDescription":"Intraductal Cribriform Breast Adenocarcinoma","ValueMeaning":{"publicId":"3249020","version":"1","preferredName":"Intraductal Cribriform Breast Adenocarcinoma","longName":"3249020","preferredDefinition":"A ductal carcinoma in situ of the breast characterized by the presence of a cribriform architectural pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ, Cribriform Pattern","conceptCode":"C5138","definition":"Breast ductal carcinoma in situ characterized by the presence of a cribriform architectural pattern.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-1614-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A1B1051-84C1-78B4-E053-F662850A25B7","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"ONEDATA","dateModified":"2019-05-30","deletedIndicator":"No"},{"value":"Solid","valueDescription":"Ductal Breast Carcinoma In Situ, Solid Type","ValueMeaning":{"publicId":"3249008","version":"1","preferredName":"Ductal Breast Carcinoma In Situ, Solid Type","longName":"3249008","preferredDefinition":"A ductal carcinoma in situ of the breast in which the tumor cells fill the ductal spaces as solid sheets.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ, Solid Type","conceptCode":"C66933","definition":"Breast ductal carcinoma in situ in which the tumor cells fill the ductal spaces as solid sheets.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-1530-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A1B1051-84D6-78B4-E053-F662850A25B7","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"ONEDATA","dateModified":"2019-05-30","deletedIndicator":"No"},{"value":"Comedo","valueDescription":"High Grade Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"3249018","version":"1","preferredName":"High Grade Ductal Breast Carcinoma In Situ","longName":"3249018","preferredDefinition":"A ductal carcinoma in situ characterized by the presence of neoplastic cells with severe dysplasia and the formation of micropapillary, cribriform, or solid patterns. The nuclei show marked pleomorphism and have prominent nucleoli. Mitotic activity is usually present. There is comedo-type of necrosis present in the ducts. The necrotic debris is surrounded by pleomorphic malignant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ, High Grade","conceptCode":"C7949","definition":"Breast ductal carcinoma in situ characterized by the presence of neoplastic cells with severe dysplasia and the formation of micropapillary, cribriform, or solid patterns. The nuclei show marked pleomorphism and have prominent nucleoli. Mitotic activity is usually present. There is comedo-type of necrosis present in the ducts. The necrotic debris is surrounded by pleomorphic malignant cells.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-15EE-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A1B1051-84EB-78B4-E053-F662850A25B7","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"ONEDATA","dateModified":"2019-05-30","deletedIndicator":"No"},{"value":"Apocrine","valueDescription":"Apocrine Neoplasm","ValueMeaning":{"publicId":"3247905","version":"1","preferredName":"Apocrine Neoplasm","longName":"3247905","preferredDefinition":"A benign or malignant sweat gland neoplasm with apocrine differentiation. Representative examples include apocrine adenoma, ceruminous adenocarcinoma, and apocrine breast carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Apocrine Neoplasm","conceptCode":"C6798","definition":"A benign or malignant sweat gland neoplasm with apocrine differentiation. Representative examples include apocrine adenoma, ceruminous adenocarcinoma, and apocrine breast carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67B3AED-0439-CE90-E040-BB89AD433EDB","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"951C778C-8079-460E-E053-F662850ACDDB","beginDate":"2019-10-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-17","modifiedBy":"ONEDATA","dateModified":"2019-10-17","deletedIndicator":"No"},{"value":"Papillary","valueDescription":"Papillary Carcinoma","ValueMeaning":{"publicId":"4264950","version":"1","preferredName":"Papillary Carcinoma","longName":"4264950","preferredDefinition":"A malignant epithelial neoplasm characterized by a papillary growth pattern. A papillary carcinoma may be composed of glandular cells (papillary adenocarcinoma), squamous cells (papillary squamous cell carcinoma), or transitional cells (papillary transitional cell carcinoma). Bladder carcinoma is a representative example of papillary transitional cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Carcinoma","conceptCode":"C2927","definition":"A malignant epithelial neoplasm characterized by a papillary growth pattern. A papillary carcinoma may be composed of glandular cells (papillary adenocarcinoma), squamous cells (papillary squamous cell carcinoma), or transitional cells (papillary transitional cell carcinoma). Bladder carcinoma is a representative example of papillary transitional cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3955-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"951C778C-808E-460E-E053-F662850ACDDB","beginDate":"2019-10-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-17","modifiedBy":"ONEDATA","dateModified":"2019-10-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"8072468","version":"1","preferredName":"Breast Ductal Carcinoma In Situ Subtype Type","preferredDefinition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.:A group forming a type within a larger type.:Something distinguishable as an identifiable class based on common qualities.","longName":"C2924:C25696:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9B73D2B-E57E-4DA6-E053-4EBD850A6F9D","latestVersionIndicator":"Yes","beginDate":"2022-03-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2022-03-08","modifiedBy":"ONEDATA","dateModified":"2022-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A1B1051-8476-78B4-E053-F662850A25B7","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeDescription":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  10/17/19 jk C6798 and Papillary added for LabCAS PCA pilot project.  5-30-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506112","version":"1","longName":"Breast","context":"MCL","ClassificationSchemeItems":[{"publicId":"6643181","version":"1","longName":"Initial Diagnosis","context":"MCL"}]},{"publicId":"5855817","version":"1","longName":"LabCAS","context":"MCL","ClassificationSchemeItems":[{"publicId":"6944398","version":"1","longName":"MCL PCA Pilot","context":"MCL"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"DCIS Histologic Subtype","type":"Preferred Question Text","description":"DCIS Histologic Subtype","url":null,"context":"MCL"}],"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A1DD4A5-098F-1496-E053-F662850AD292","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeDescription":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  10/14/19 jk classified for MCL PCA genomic pilot project.  5-30-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}